Amgen

Based in DC

🤖

AI Overview

With $1.4M in lobbying spend across 27 quarterly filings, Amgen is a significant lobbying presence.

$1.4M
Total Lobbying Spend
27
Quarterly Filings
1
Lobbying Firms Used
6
Individual Lobbyists

Spending by Year

YearLobbying Spend
2018$150K
2019$150K
2020$100K
2021$200K
2022$200K
2023$200K
2024$200K
2025$150K

Lobbying Firms

ALPINE GROUP PARTNERS, LLC.

What They Lobby For

  • Issues related to 340B
  • Issues related to Part B Issues related to Part D
  • Issues related to Part B and Part D
  • Issues related to Part B and Part D H.R. 2693 S. 283
  • issues related to Part B, Part D and the ESRD program
  • issues related to Part B, Part D and the ESRD program H.R.3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
  • issues related to Part B, Part D and the ESRD program H.R.3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021
  • Issues related to cardiovascular disease
  • Issues related to Part B, Part D and the ESRD program H.R.3517 - Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2021 Issues related to Part D rebates
  • Issues related to Part B, Part D and the ESRD program Issues related to Part D rebates Proposals related to drug pricing, drug price transparency, PBMS Implementation of the Inflation Reduction Act

Related Investigations

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.